세계의 프라스테론(CAS 53-43-0) 시장(2025년)

The global Prasterone (CAS 53-43-0) market was valued at US$ 49.28 million in 2024 and is anticipated to reach US$ 75.92 million by 2031, witnessing a CAGR of 7.17% during the forecast period 2025-2031.

North American market for Prasterone (CAS 53-43-0) is estimated to increase from $ 14.52 million in 2024 to reach $ 23.18 million by 2031, at a CAGR of 7.18% during the forecast period of 2025 through 2031.

Asia-Pacific market for Prasterone (CAS 53-43-0) is estimated to increase from $ 27.62 million in 2024 to reach $ 42.47 million by 2031, at a CAGR of 7.55% during the forecast period of 2025 through 2031.

The major global manufacturers of Prasterone (CAS 53-43-0) include Yicheng Goto Pharmaceutical, Junye Pharmaceutical, Hubei Dan'ao Pharmaceutical, Hubei Zhuxi Humanwell Pharmaceutical and Shandong Saito Biotechnology, and etc. In 2024, the world's top five vendors accounted for 73.42% of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prasterone (CAS 53-43-0), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prasterone (CAS 53-43-0).

The Prasterone (CAS 53-43-0) market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prasterone (CAS 53-43-0) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prasterone (CAS 53-43-0) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Yicheng Goto Pharmaceutical
• Junye Pharmaceutical
• Hubei Dan'ao Pharmaceutical
• Hubei Zhuxi Humanwell Pharmaceutical
• Shandong Saito Biotechnology
• Jiangsu Jiaerke Pharmaceutical
• Zhejiang Shenzhou Pharmaceutical
• Wudang Antai Pharmaceutical
• Symbiotec
• NutriScience Innovations

Segment by Type

• >=99%
• Others

Segment by Application

• Medicine
• Dietary Supplements
• Skin Care Products
• Reagents
• Others

Production by Region

• North America
• Europe
• China

Consumption by Region

• North America
• U.S.
• Canada
• Asia-Pacific
• China
• Japan
• India
• Europe
• Germany
• France
• U.K.
• Italy
• Rest of Europe
• Latin America, Middle East & Africa

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Prasterone (CAS 53-43-0) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Production/output, value of Prasterone (CAS 53-43-0) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 4: Consumption of Prasterone (CAS 53-43-0) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: The main points and conclusions of the report.

Table of Contents

1 Prasterone (CAS 53-43-0) Market Overview

• 1.1 Product Definition
• 1.2 Prasterone (CAS 53-43-0) by Type
  • 1.2.1 Global Prasterone (CAS 53-43-0) Market Value Growth Rate Analysis by Type: 2024 VS 2031
  • 1.2.2 >= 99)
  • 1.2.3 Others
• 1.3 Prasterone (CAS 53-43-0) by Application
  • 1.3.1 Global Prasterone (CAS 53-43-0) Market Value Growth Rate Analysis by Application: 2024 VS 2031
  • 1.3.2 Medicine
  • 1.3.3 Dietary Supplements
  • 1.3.4 Skin Care Products
  • 1.3.5 Reagents
  • 1.3.6 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)
  • 1.4.2 Global Prasterone (CAS 53-43-0) Production Capacity Estimates and Forecasts (2020-2031)
  • 1.4.3 Global Prasterone (CAS 53-43-0) Production Estimates and Forecasts (2020-2031)
  • 1.4.4 Global Prasterone (CAS 53-43-0) Market Average Price Estimates and Forecasts (2020-2031)
• 1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

• 2.1 Global Prasterone (CAS 53-43-0) Production Market Share by Manufacturers (2020-2025)
• 2.2 Global Prasterone (CAS 53-43-0) Production Value Market Share by Manufacturers (2020-2025)
• 2.3 Global Key Players of Prasterone (CAS 53-43-0), Industry Ranking, 2024 VS 2025
• 2.4 Global Prasterone (CAS 53-43-0) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.5 Global Prasterone (CAS 53-43-0) Average Price by Manufacturers (2020-2025)
• 2.6 Global Key Manufacturers of Prasterone (CAS 53-43-0), Manufacturing Sites & Headquarters
• 2.7 Global Key Manufacturers of Prasterone (CAS 53-43-0), Product Type & Application
• 2.8 Global Prasterone (CAS 53-43-0) Market Competitive Situation and Trends
  • 2.8.1 Global Prasterone (CAS 53-43-0) Market Concentration Rate
  • 2.8.2 Global 5 and 10 Largest Prasterone (CAS 53-43-0) Players Market Share by Revenue

3 Prasterone (CAS 53-43-0) Production by Region

• 3.1 Global Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.2 Global Prasterone (CAS 53-43-0) Production Value by Region (2020-2031)
  • 3.2.1 Global Prasterone (CAS 53-43-0) Production Value Market Share by Region (2020-2025)
  • 3.2.2 Global Forecasted Production Value of Prasterone (CAS 53-43-0) by Region (2026-2031)
• 3.3 Global Prasterone (CAS 53-43-0) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 3.4 Global Prasterone (CAS 53-43-0) Production by Region (2020-2031)
  • 3.4.1 Global Prasterone (CAS 53-43-0) Production Market Share by Region (2020-2025)
  • 3.4.2 Global Forecasted Production of Prasterone (CAS 53-43-0) by Region (2026-2031)
• 3.5 Global Prasterone (CAS 53-43-0) Market Price Analysis by Region (2020-2025)
• 3.6 Global Prasterone (CAS 53-43-0) Production and Value, Year-over-Year Growth
  • 3.6.1 North America Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)
  • 3.6.2 Europe Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)
  • 3.6.3 China Prasterone (CAS 53-43-0) Production Value Estimates and Forecasts (2020-2031)

4 Prasterone (CAS 53-43-0) Consumption by Region

• 4.1 Global Prasterone (CAS 53-43-0) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
• 4.2 Global Prasterone (CAS 53-43-0) Consumption by Region (2020-2031)
  • 4.2.1 Global Prasterone (CAS 53-43-0) Consumption by Region (2020-2031)
  • 4.2.2 Global Prasterone (CAS 53-43-0) Forecasted Consumption by Region (2026-2031)
• 4.3 North America
  • 4.3.1 North America Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.3.2 North America Prasterone (CAS 53-43-0) Consumption by Country (2020-2031)
  • 4.3.3 U.S.
  • 4.3.4 Canada
• 4.4 Europe
  • 4.4.1 Europe Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.4.2 Europe Prasterone (CAS 53-43-0) Consumption by Country (2020-2031)
  • 4.4.3 Germany
  • 4.4.4 France
  • 4.4.5 U.K.
  • 4.4.6 Italy
• 4.5 Asia Pacific
  • 4.5.1 Asia Pacific Prasterone (CAS 53-43-0) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
  • 4.5.2 Asia Pacific Prasterone (CAS 53-43-0) Consumption by Region (2020-2031)
  • 4.5.3 China
  • 4.5.4 Japan
  • 4.5.5 India
• 4.6 Latin America
• 4.7 Middle East and Africa

5 Segment by Type

• 5.1 Global Prasterone (CAS 53-43-0) Production by Type (2020-2031)
  • 5.1.1 Global Prasterone (CAS 53-43-0) Production by Type (2020-2025)
  • 5.1.2 Global Prasterone (CAS 53-43-0) Production by Type (2026-2031)
  • 5.1.3 Global Prasterone (CAS 53-43-0) Production Market Share by Type (2020-2031)
• 5.2 Global Prasterone (CAS 53-43-0) Production Value by Type (2020-2031)
  • 5.2.1 Global Prasterone (CAS 53-43-0) Production Value by Type (2020-2025)
  • 5.2.2 Global Prasterone (CAS 53-43-0) Production Value by Type (2026-2031)
  • 5.2.3 Global Prasterone (CAS 53-43-0) Production Value Market Share by Type (2020-2031)
• 5.3 Global Prasterone (CAS 53-43-0) Price by Type (2020-2031)

6 Segment by Application

• 6.1 Global Prasterone (CAS 53-43-0) Production by Application (2020-2031)
  • 6.1.1 Global Prasterone (CAS 53-43-0) Production by Application (2020-2025)
  • 6.1.2 Global Prasterone (CAS 53-43-0) Production by Application (2026-2031)
  • 6.1.3 Global Prasterone (CAS 53-43-0) Production Market Share by Application (2020-2031)
• 6.2 Global Prasterone (CAS 53-43-0) Production Value by Application (2020-2031)
  • 6.2.1 Global Prasterone (CAS 53-43-0) Production Value by Application (2020-2025)
  • 6.2.2 Global Prasterone (CAS 53-43-0) Production Value by Application (2026-2031)
  • 6.2.3 Global Prasterone (CAS 53-43-0) Production Value Market Share by Application (2020-2031)
• 6.3 Global Prasterone (CAS 53-43-0) Price by Application (2020-2031)

7 Key Companies Profiled

• 7.1 Yicheng Goto Pharmaceuticals Co.,Ltd.
  • 7.1.1 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.1.2 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.1.3 Yicheng Goto Pharmaceuticals Co.,Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.1.4 Yicheng Goto Pharmaceuticals Co.,Ltd. Main Business and Markets Served
• 7.2 Junye Pharmaceutical Co., Ltd.
  • 7.2.1 Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.2.2 Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.2.3 Junye Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.2.4 Junye Pharmaceutical Co., Ltd. Main Business and Markets Served
• 7.3 Hubei Dan'ao Pharmaceutical Co., Ltd.
  • 7.3.1 Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.3.2 Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.3.3 Hubei Dan'ao Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.3.4 Hubei Dan'ao Pharmaceutical Co., Ltd. Main Business and Markets Served
• 7.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd.
  • 7.4.1 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.4.2 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.4.3 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.4.4 Hubei Zhuxi Humanwell Pharmaceutical Co., Ltd. Main Business and Markets Served
• 7.5 Shandong Saito Biotechnology Co., Ltd.
  • 7.5.1 Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.5.2 Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.5.3 Shandong Saito Biotechnology Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.5.4 Shandong Saito Biotechnology Co., Ltd. Main Business and Markets Served
• 7.6 Jiangsu Jiaerke Pharmaceuticals Group
  • 7.6.1 Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Company Information
  • 7.6.2 Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Product Portfolio
  • 7.6.3 Jiangsu Jiaerke Pharmaceuticals Group Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.6.4 Jiangsu Jiaerke Pharmaceuticals Group Main Business and Markets Served
• 7.7 Zhejiang Shenzhou Pharmaceutical Co., Ltd.
  • 7.7.1 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.7.2 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.7.3 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.7.4 Zhejiang Shenzhou Pharmaceutical Co., Ltd. Main Business and Markets Served
• 7.8 HuBei WuDang AnTai Pharmaceutical Co
  • 7.8.1 HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Company Information
  • 7.8.2 HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Product Portfolio
  • 7.8.3 HuBei WuDang AnTai Pharmaceutical Co Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.8.4 HuBei WuDang AnTai Pharmaceutical Co Main Business and Markets Served
• 7.9 Symbiotec Pharma Lab Pvt. Ltd.
  • 7.9.1 Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Company Information
  • 7.9.2 Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Product Portfolio
  • 7.9.3 Symbiotec Pharma Lab Pvt. Ltd. Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.9.4 Symbiotec Pharma Lab Pvt. Ltd. Main Business and Markets Served
• 7.10 NutriScience Innovations, LLC
  • 7.10.1 NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Company Information
  • 7.10.2 NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Product Portfolio
  • 7.10.3 NutriScience Innovations, LLC Prasterone (CAS 53-43-0) Production, Value, Price and Gross Margin (2020-2025)
  • 7.10.4 NutriScience Innovations, LLC Main Business and Markets Served
  • 7.10.5 NutriScience Innovations, LLC Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

• 8.1 Prasterone (CAS 53-43-0) Industry Chain Analysis
• 8.2 Prasterone (CAS 53-43-0) Raw Material Supply Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
• 8.3 Prasterone (CAS 53-43-0) Production Mode & Process Analysis
• 8.4 Prasterone (CAS 53-43-0) Customer Analysis

9 Prasterone (CAS 53-43-0) Market Dynamics

• 9.1 Prasterone (CAS 53-43-0) Industry Trends
• 9.2 Prasterone (CAS 53-43-0) Market Drivers
• 9.3 Prasterone (CAS 53-43-0) Market Challenges and Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

• 11.1 Methodology/Research Approach
  • 11.1.1 Research Programs/Design
  • 11.1.2 Market Size Estimation
  • 11.1.3 Market Breakdown and Data Triangulation
• 11.2 Data Source
  • 11.2.1 Secondary Sources
  • 11.2.2 Primary Sources
• 11.3 Author List
• 11.4 Disclaimer